Fate Therapeutics (FATE) Return on Sales (2016 - 2025)
Historic Return on Sales for Fate Therapeutics (FATE) over the last 14 years, with Q3 2025 value amounting to 18.47%.
- Fate Therapeutics' Return on Sales fell 28800.0% to 18.47% in Q3 2025 from the same period last year, while for Sep 2025 it was 22.7%, marking a year-over-year decrease of 94100.0%. This contributed to the annual value of 14.16% for FY2024, which is 114300.0% down from last year.
- Latest data reveals that Fate Therapeutics reported Return on Sales of 18.47% as of Q3 2025, which was down 28800.0% from 17.85% recorded in Q2 2025.
- Over the past 5 years, Fate Therapeutics' Return on Sales peaked at 0.42% during Q1 2023, and registered a low of 62.36% during Q2 2023.
- Moreover, its 5-year median value for Return on Sales was 5.94% (2024), whereas its average is 14.76%.
- Per our database at Business Quant, Fate Therapeutics' Return on Sales tumbled by -579200bps in 2023 and then surged by 564200bps in 2024.
- Over the past 5 years, Fate Therapeutics' Return on Sales (Quarter) stood at 4.05% in 2021, then surged by 66bps to 1.39% in 2022, then plummeted by -1778bps to 26.05% in 2023, then dropped by -19bps to 31.12% in 2024, then surged by 41bps to 18.47% in 2025.
- Its Return on Sales stands at 18.47% for Q3 2025, versus 17.85% for Q2 2025 and 23.29% for Q1 2025.